2 Minute Medicine Podcast and News Update - Weekly Rewind December 7, 2015
150 minutes of moderate-to-vigorous physical activity per week may reduce cardiovascular risk in overweight or obese adults
2 Minute Medicine: Pharma Roundup – Merck and Mayo Clinic’s AI precision medicine lab, Novartis’ remibrutinib hits Phase III hive endpoint, FDA grants priority review for iberdomide in myeloma, oral infigratinib boosts growth velocity in achondroplasia, and shingles vaccine/sildenafil linked to lower Alzheimer’s risk [February 2026]
Virtual reality rehabilitation is safe and feasible for upper extremity recovery after subacute ischemic stroke
Cardiology 150 minutes of moderate-to-vigorous physical activity per week may reduce cardiovascular risk in overweight or obese adults February 26, 2026
Chronic Disease 2 Minute Medicine: Pharma Roundup – Merck and Mayo Clinic’s AI precision medicine lab, Novartis’ remibrutinib hits Phase III hive endpoint, FDA grants priority review for iberdomide in myeloma, oral infigratinib boosts growth velocity in achondroplasia, and shingles vaccine/sildenafil linked to lower Alzheimer’s risk [February 2026] February 26, 2026
Chronic Disease Virtual reality rehabilitation is safe and feasible for upper extremity recovery after subacute ischemic stroke February 25, 2026
Chronic Disease Safety and efficacy of novel antibody-oligonucleotide therapy for myotonic dystrophy type 1 February 25, 2026
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)
